The ASSOCHAM has suggested that the Indian firms engaged in the manufacture of medical devices, be enabled faster access to the US drug and pharmaceutical regulator FDA or FDA equivalent certifications in a cost effective manner through a fast track FDA desk in India with the government, facilitating such a dispensation, according to an ASSOCHAM-MRSS India.Com joint study. The medical devices sector has been witnessing an increased interest from the MNCs which have stepped up their footprints in India, along with locating their key research centers in the Indian cities. The inflow of foreign direct investment (FDI) in medical devices was USD 90 million between December 2014 and August 2015, post the government permitting 100 percent FDI under the automatic route, jointly conducted by The Associated Chambers of Commerce and Industry of India (ASSOCHAM) and MRSSindia.com.
The global medical devices and technology market is expected to grow to USD 520 billion by 2020. The Indian market is among the top 20 in the world by market size, and fourth in Asia after Japan, China and South Korea, the study noted. Financial measures need to be undertaken to incentivise manufacturing in this emerging sector and specifically in creating an ecosystem in the early stages of the manufacturing. The scope for expansion is huge as India’s per capita spend on medical devices is the lowest among the BRIC (Brazil, Russia, India and China) countries, India spends a meagre share of USD 3 less than China (USD 7), Brazil (USD 21) and Russia (USD 42) which is significantly behind developed economies like the US (USD 340), noted the study, indicating a huge potential in the untapped areas.
Indian medical device industry is worth over ₹60,000 crore even as country’s import bill for this segment amounts to over ₹23,000 crore while exports amount to about ₹7000 crore, it said. The ASSOCHAM suggested that parity of duty on raw materials with finished goods should be maintained to enable the industry move from the inverted duty structure. Focus can be given on product segments ranging from low to medium technology and with a precedence of manufacturing in India in the short term. These include disposables, consumables, certain imaging equipment, implants, stents, some categories of laboratory diagnostics equipment, innovative mHealth based solutions etc. Indigenous manufacture in these items can be provided incentives.
The Government plays a critical role in developing the ecosystem (suppliers, buyers, distribution etc.) of the medical devices industry. The Government is also a large purchaser of medical devices with its network of medical colleges, secondary care hospitals and primary healthcare through primary health centers and sub centers. Various other Government programs also require consumption of medical diagnostics and devices. The Government can play a role in enabling medical devices manufacturers with faster access to FDA or FDA equivalent certifications in a cost effective manner. A possible option is to set-up a fast track FDA desk in India, with the Government of India subsidizing certification expenses. – Medical Buyer Bureau